Natália Satchiko Hojo-Souza (Natália S Hojo-Souza, Natalia S Hojo-Souza)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Regulatory T Cells

Respiratory Syndrome Coronavirus

Top Venues

Nanomedicine (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Julia T Castro, Rory Cristiane Fortes de Brito, Natália Satchiko Hojo-Souza, Bárbara Azevedo, Natalia Salazar, Camila P Ferreira, Caroline Junqueira, Ana Paula Fernandes, Ronnie Vasconcellos, Jamille M Cardoso, Rodrigo D O Aguiar-Soares, Paula M A Vieira, Cláudia M Carneiro, Bruno Valiate, Cristiane Toledo, Andres M Salazar, Otávia Caballero, Joseli Lannes-Vieira, Santuza R Teixeira, Alexandre Barbosa Reis, Ricardo Tostes Gazzinelli
ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas' disease. NPJ vaccines 8 (1) (2023)
Patrick Orestes de Azevedo, Natália Satchiko Hojo-Souza, Lídia P Faustino, Marcílio J Fumagalli, Isabella C Hirako, Emiliano R Oliveira, Maria M Figueiredo, Alex F Carvalho, Daniel Doro, Luciana Benevides, Edison Durigon, Flávio Fonseca, Alexandre M Machado, Ana P Fernandes, Santuza R Teixeira, João S Silva, Ricardo Tostes Gazzinelli
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern. NPJ vaccines 8 (1) (2023)
Patrick Orestes de Azevedo, Natália Satchiko Hojo-Souza, Lídia P Faustino, Marcílio J Fumagalli, Isabella C Hirako, Emiliano R Oliveira, Maria M Figueiredo, Alex F Carvalho, Daniel Doro, Luciana Benevides, Edison Durigon, Flávio Fonseca, Alexandre M Machado, Ana P Fernandes, Santuza R Teixeira, João S Silva, Ricardo Tostes Gazzinelli
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern. NPJ vaccines 8 (1) (2023)
Bruna Rodrigues Dias Assis, Isabela Pereira Gomes, Júlia Teixeira de Castro, Graziella Gomes Rivelli, Natália Salazar de Castro, Diana Paola Gomez-Mendoza, Flávia Fonseca Bagno, Natália Satchiko Hojo-Souza, Ana Luiza Chaves Maia, Eduardo Burgarelli Lages, Flavio Guimarães da Fonseca, Santuza Maria Ribeiro Teixeira, Ana Paula Fernandes, Ricardo Tostes Gazzinelli, Gisele Assis Castro Goulart
Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine. Nanomedicine (London, England) (2023)